Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Emergency Medicine Management of Sickle Cell Disease Complications: An Evidence-Based Update
source: The Journal of Emergency Medicine
year: 2016
authors: Simon E, Long B, Koyfman A
summary/abstract:BACKGROUND:
Sickle cell disease (SCD) affects approximately 100,000 individuals in the United States. Due to alterations in the structural conformation of hemoglobin molecules under deoxygenated conditions, patients with SCD are predisposed to numerous sequelae, many of which require acute intervention.
OBJECTIVE:
Our aim was to provide emergency physicians with an evidence-based update regarding the diagnosis and management of SCD complications.
DISCUSSION:
SCD patients experience significant morbidity and mortality secondary to cerebrovascular accident, acute chest syndrome, acute vaso-occlusive pain crises, SCD-related multi-organ failure, cholecystitis, acute intrahepatic cholestasis, acute sickle hepatic crisis, acute hepatic sequestration, priapism, and renal disease. Emergency physicians must recognize acute manifestations of SCD in order to deliver timely management and determine patient disposition.
CONCLUSIONS:
A comprehensive review of the emergency department management of acute SCD complications is provided. Comprehensive understanding of these aspects of SCD can assist physicians in expediting patient evaluation and treatment, thus decreasing the morbidity and mortality associated with this hemoglobinopathy.
DOI: 10.1016/j.jemermed.2016.05.042
read more full text
+myBinderRelated Content
-
Deepa G. Manwani, MDDr. Manwani completed her residency (199...
-
Access to Care, and Emergency Department Utilization for Adults and Adolescents With Sickle Cell Disease: Ascq-Me an...Measurement of access to care and utiliz...
-
Robert Molokie, MDDr. Robert Molokie is a hematologist and...
-
Caries prevalence and impact on oral health-related quality of life in children with sickle cell disease: cross-sect...BACKGROUND: Children with sickle cell di...
-
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...
-
Today’s Faces of Sickle Cell Disease: Tesha SamuelsTesha Samuels was diagnosed with SCD at ...
-
University of Pittsburgh School of MedicineThe University of Pittsburgh School of M...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.